MRK Investors Have Final Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm

Group 1 - The Schall Law Firm has initiated a class action lawsuit against Merck & Co., Inc. for alleged violations of the Securities Exchange Act of 1934 [1][4] - The lawsuit pertains to investors who purchased Merck's securities between February 3, 2022, and February 3, 2025, and encourages them to contact the firm before April 14, 2025 [2] - The complaint alleges that Merck made false and misleading statements regarding the demand for its product Gardasil, particularly in China, while concealing negative facts about inventory levels [4] Group 2 - The lawsuit claims that Merck's public statements were materially misleading, leading to investor damages when the truth about the company's situation was revealed [4] - The Schall Law Firm specializes in securities class action lawsuits and represents investors globally [5]